×
<- Back

145094 - Allergic rhinoconjunctivitis. Allergen-specific immunotherapy options in Australia

  • : Online

This free online learning module provides 15 clinical questions and immediate answers about an original peer-reviewed article written for GPs.

Relevance to General Practice

Allergen-specific immunotherapy (AIT) has traditionally been reserved for patients with moderate-to-severe allergic rhinoconjunctivitis refractory to maximal pharmacotherapy. 
However, evidence is mounting that AIT should be considered not just a symptom-control measure but also a curative tool that may alter the course of allergic disease. 
Although specialist assessment is required to initiate AIT, GP familiarity with its administration, risks and benefits is crucial to maximising patient safety and satisfaction.

Learning outcomes
  • Recognise symptoms suggestive of allergic rhinoconjunctivitis and arrange investigations
  • Describe how allergen-specific immunotherapy (AIT) works and how it is used
  • Identify contraindications and side effects of AIT
  • Assist patients to make personalised choices about how best to access AIT
  • Delivery
    Title
    145094 - Allergic rhinoconjunctivitis. Allergen-specific immunotherapy options in Australia
    Location
    Provider Type
    Education Provider
    Duration
    1.5 hours
    Start Date
    19-Oct-2018
    End Date
    19-Dec-2019
    CPD
    1.5 hours
    Price
    0.00
    Location
    Online
    Contact Phone
    Log in into view this field.
    5 Views
    Similar Courses and Events
    HealthcareLink